MENU
FOLD
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
Amicus Therapeutics (FOLD) Ownership - Who owns Amicus Therapeutics?
Industry: @Biotechnology
Profile
Industry
Biotechnology
Address
47 Hulfish Street
Phone
+1 609 662-2000
Employees
517
Web
https://www.amicusrx.com
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
2.93B
P/E Ratio
N/A
Total Cash
249.76M
Projected Growth
N/A
Total Debt
444.66M
Revenue
493.67M
Risk (Beta)
0.40
Dividend Yield
N/A
Total Cash/Share
0.84
Total Debt/Equity
46.37
Revenue/Share
1.63 USD as % of share price
Fundamentals
FOLD
Capitalization
2.93B
P/E Ratio
N/A
Risk (Beta)
0.40
Dividend Yield
N/A
Total Cash
250M
Total Cash/Share
0.84
Total Debt
445M
Total Debt/Equity
46.37
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
1.63%
Revenue
494M
ROE
N/A
Book Value
179M
P/B Ratio
16.37
Cash Flow
N/A
Earnings
-0.34
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
2.94M
Current Ratio
3.15
Current Revenue Per Employee
273727.28
Dividends Per Share - Security
N/A
EBITDA
-9.2M
Float
N/A
Float - Current
N/A
Gross Income Margin
90.62
Revenue To Assets
-13.50
Shares Held By Institutions
8.1B
Shares Outstanding - Current
299M
Total Liabilities
608M
Total Volume MTD
N/A
Value
-1
Gain YTD
-30.937
View a ticker or compare two or three
VS
VS
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information
General Information
a developer of orally active drugs to treat human genetic diseases
Industry Biotechnology
Profile
Fundamentals
Details
Industry
Biotechnology
Address
47 Hulfish Street
Phone
+1 609 662-2000
Employees
517
Web
https://www.amicusrx.com